With Connecticut leading the charge, Johnson & Johnson and its subsidiary Ethicon Inc. will pay roughly $116.9 million to resolve allegations of deceptive marketing of transvaginal surgical mesh devices.

Connecticut’s portion of the settlement totals almost $2 million.